Boston Scientific announces results for second quarter 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Boston Scientific (BSX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
July 29, 2026 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $5.44 billion versus the consensus estimate of $5.37 billion.
GUIDANCE:
Boston Scientific sees FY2026 EPS of $3.28-$3.32, versus the consensus of... More
